Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy

Seminars in Hematology

Volumn 37, Issue 4 SUPPL. 6, 2000, Pages 18-23

  Moore, Richard D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; DAPSONE; FLUCYTOSINE; FOSCARNET; GANCICLOVIR; HYDROXYUREA; PENTAMIDINE; PYRIMETHAMINE; RECOMBINANT ERYTHROPOIETIN; RIBAVIRIN; SULFONAMIDE; ZIDOVUDINE;

ANEMIA; CONFERENCE PAPER; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SURVIVAL;

EID: 0033790464     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/shem.2000.18120     Document Type: Conference Paper

References (14)

1. Human immunodeficiency virus infection, anemia, and survival
2. Natural history of HIV infection in the era of combination ancirecroviral therapy
3. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
4. AIDS-related opportunistic illnesses occurring after initiation of porent antirerroviral rherapy
5. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project
6. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
7. Anemia in HIV disease in the HAART era: Is it common?
8. Improved survival with correction of anemia in HIV disease
9. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia
10. Epoetin alfa improves the quality of life (QOL) in HIV+ patients with anemia
11. Once-weekly dosing of epoetin alfa increases hemoglobin and quality of life in HIV-positive patients with anemia
12. Anemia and survival in HIV infection
13. + lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time
14. A case-control study examining the association of disease prognosis with the development and treatment of anemia in patients infected with HIV